SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-06-044661
Filing Date
2006-03-03
Accepted
2006-03-03 11:23:51
Documents
2
Period of Report
2006-02-27
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 PHARMACEUTICAL PRODUCT DEVELOPMENT d8k.htm 8-K 13340
2 CONSTRUCTION LOAN AGREEMENT dex10420.htm EX-10.420 201945
  Complete submission text file 0001193125-06-044661.txt   216953
Mailing Address 3151 SOUTH 17TH ST WILMINGTON NC 28412
Business Address 3151 SOUTH 17TH ST WILMINGTON NC 28412 9102510081
PHARMACEUTICAL PRODUCT DEVELOPMENT INC (Filer) CIK: 0001003124 (see all company filings)

IRS No.: 561640186 | State of Incorp.: NC | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-27570 | Film No.: 06662282
SIC: 8731 Services-Commercial Physical & Biological Research